Prescriptions for Mounjaro jabs, to help people lose weight, will be available at GP surgeries in England from today - but only for those who meet very strict criteria. NHS England says while the long-term plan is for the jabs to be more widely available,

People started on a low dose of Amgen's long-acting experimental obesity drug MariTide lost as much weight as those given high doses but with milder side effects, according to full results of a mid-stage trial presented at a medical meeting on Monday.

A mass rollout of weight loss injections begins across the NHS on Monday, with GPs able to prescribe Mounjaro for the first time. The drug, also known as tirzepatide and manufactured by Lilly, is an antidiabetic medication that works by lowering blood sugar levels and slowing down the digestion of food.